Variant report
Variant | nsv526500 |
---|---|
Chromosome Location | chr7:80870379-80880682 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:12)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:80880483..80882765-chr7:80886437..80888337,2 | MCF-7 | breast: | |
2 | chr7:80874756..80878864-chr7:80882916..80885687,3 | MCF-7 | breast: | |
3 | chr7:80545834..80553200-chr7:80879354..80888784,34 | MCF-7 | breast: | |
4 | chr7:80878793..80880678-chr7:80882418..80884824,2 | MCF-7 | breast: | |
5 | chr7:80873781..80875540-chr7:80877890..80879810,2 | MCF-7 | breast: | |
6 | chr7:80550385..80552330-chr7:80878720..80881431,3 | MCF-7 | breast: | |
7 | chr7:80860012..80862237-chr7:80868922..80870450,2 | MCF-7 | breast: | |
8 | chr7:80543196..80546765-chr7:80879476..80881407,3 | MCF-7 | breast: | |
9 | chr7:80873599..80875269-chr7:80889100..80891084,2 | K562 | blood: | |
10 | chr7:80873781..80875540-chr7:80877890..80879810,2 | MCF-7 | breast: | |
11 | chr7:80878967..80881454-chr7:80884468..80886098,2 | MCF-7 | breast: | |
12 | chr7:80547067..80548800-chr7:80871379..80875196,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000075223 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17154974 | chr7:80870379-80870380 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs182675924 | chr7:80870398-80870399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564742713 | chr7:80870443-80870444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568644184 | chr7:80870451-80870452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545644001 | chr7:80870454-80870455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372950718 | chr7:80870467-80870468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148270951 | chr7:80870472-80870473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs151314310 | chr7:80870532-80870533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551283366 | chr7:80870575-80870576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141774753 | chr7:80870590-80870591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12531400 | chr7:80870628-80870629 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs552887641 | chr7:80870634-80870635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs566454424 | chr7:80870645-80870646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs370254421 | chr7:80870650-80870651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs77872813 | chr7:80870653-80870654 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555300453 | chr7:80870667-80870668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544846039 | chr7:80870668-80870669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537149536 | chr7:80870669-80870670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186732758 | chr7:80870697-80870698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191911924 | chr7:80870712-80870713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs71520741 | chr7:80870729-80870730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs36115707 | chr7:80870732-80870733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs78001355 | chr7:80870733-80870734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184159744 | chr7:80870749-80870750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6965375 | chr7:80870770-80870771 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs187525592 | chr7:80870798-80870799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192825181 | chr7:80870829-80870830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559663469 | chr7:80870836-80870837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185754086 | chr7:80870844-80870845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190283033 | chr7:80870922-80870923 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs377731708 | chr7:80870933-80870934 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529263565 | chr7:80870944-80870945 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550154254 | chr7:80870947-80870948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145520122 | chr7:80870977-80870978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs73380419 | chr7:80870984-80870985 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs569132575 | chr7:80871012-80871013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73380421 | chr7:80871043-80871044 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs182303535 | chr7:80871084-80871085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546295403 | chr7:80871106-80871107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147716210 | chr7:80871123-80871124 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569819783 | chr7:80871126-80871127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201973483 | chr7:80871144-80871145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142096686 | chr7:80871174-80871175 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551583612 | chr7:80871214-80871215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548659007 | chr7:80871246-80871247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183753095 | chr7:80871271-80871272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs28368562 | chr7:80871278-80871279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537650241 | chr7:80871294-80871295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558499563 | chr7:80871306-80871307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79259907 | chr7:80871312-80871313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Biliary cancer | 19435499 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Williams-beuren syndrome | 16826523 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 19318497 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:80865200-80875200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr7:80869400-80871600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr7:80870600-80870800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr7:80870600-80871000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr7:80870600-80871000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr7:80870600-80871000 | Enhancers | HMEC | breast |
7 | chr7:80870600-80871200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr7:80870800-80893400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr7:80871600-80872200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr7:80871600-80872400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr7:80873000-80873200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr7:80873000-80874200 | Enhancers | Fetal Lung | lung |
13 | chr7:80873600-80874000 | Enhancers | Brain Germinal Matrix | brain |
14 | chr7:80873600-80874400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr7:80874000-80875200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr7:80874200-80875400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr7:80874400-80874800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr7:80874400-80875200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
19 | chr7:80874400-80875200 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
20 | chr7:80874800-80875200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
21 | chr7:80875200-80875400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
22 | chr7:80875200-80875400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
23 | chr7:80877600-80879000 | Enhancers | A549 | lung |